Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB8 | P28062 | 2/20 | 0.36 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL43576 | 0.94 | PSMB8 (0.35) | PSMB8PSMB5MGLLLMNA | |
| Ethylene Glycol SCHEMBL2467342 | 0.93 | PSMB8 (0.35) | PSMB8PSMB5MGLLLMNA | |
| Ethylene Glycol SCHEMBL6523939 | 0.92 | PSMB8 (0.34) | PSMB8PSMB5MGLL | |
| SCHEMBL2607886 | 0.92 | PSMB8 (0.38) | PSMB8PSMB5MGLLLMNA | |
| SCHEMBL31522720 | 0.91 | PSMB8 (0.34) | PSMB8PSMB5MGLLLMNA | |
| SCHEMBL2607893 | 0.89 | PSMB8 (0.35) | PSMB8PSMB5MGLL | |
| Ethylene Glycol SCHEMBL28215416 | 0.89 | ALDH1A1 (0.39) | PSMB8PSMB5 | |
| SCHEMBL34437 | 0.88 | PSMB8 (0.34) | PSMB8PSMB5MGLL | |
| Urea SCHEMBL4909809 | 0.88 | PSMB8 (0.34) | PSMB8PSMB5 | |
| SCHEMBL14644916 | 0.88 | PSMB8 (0.33) | PSMB8PSMB5MGLLLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | Sixfold Bioscience Ltd. (GB) | 2025-11-18 | — | — | US | claimed |
| US-12012619-B2 | Methods of use for an NADPH-regeneration system based on a monomeric isocitrate dehydrogenase | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2024-06-18 | — | — | US | claimed |
| US-20230143972-A1 | NADPH-REGENERATION SYSTEM BASED ON MONOMERIC ISOCITRATE DEHYDROGENASE AND USE THEREOF | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2023-05-11 | — | — | US | claimed |
| US-20220370635-A1 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY | SIXFOLD BIOSCIENCE LTD (GB) | 2022-11-24 | — | — | US | claimed |
| US-20220267742-A1 | NADPH-REGENERATION SYSTEM BASED ON MONOMERIC ISOCITRATE DEHYDROGENASE AND USE THEREOF | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY (KR) | 2022-08-25 | — | — | US | claimed |
| US-11357865-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | Sixfold Bioscience Ltd. (GB) | 2022-06-14 | — | — | US | claimed |
| US-20210330810-A1 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY | Sixfold Bioscience Ltd. (GB) | 2021-10-28 | — | — | US | claimed |
| US-9717733-B2 | Edible plant-derived microvesicle compositions including conjugated therapeutic agents and methods for using the same | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2017-08-01 | — | — | US | claimed |
| US-20160045448-A1 | EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS INCLUDING CONJUGATED THERAPEUTIC AGENTS AND METHODS FOR USING THE SAME | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION | 2016-02-18 | — | — | US | claimed |
| US-7238794-B2 | Organic conductor | FUJI XEROX CO., LTD. (JP) | 2007-07-03 | — | — | US | claimed |
| US-6995971-B2 | Capacitors including interacting separators and surfactants | MEDTRONIC, INC. (US) | 2006-02-07 | — | — | US | claimed |
| US-20040240156-A1 | Capacitors including interacting separators and surfactants | MEDTRONIC, INC. | 2004-12-02 | — | — | US | claimed |
| US-20030170692-A1 | Organic conductor | FUJI XEROX CO., LTD. (JP) | 2003-09-11 | — | — | US | claimed |
| EP-1324352-A2 | Organic conductor | FUJI XEROX CO., LTD. (JP) | 2003-07-02 | — | — | EP | claimed |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | Sixfold Bioscience Ltd. (GB) | 2025-11-18 | — | — | US | disclosed |
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | disclosed |
| EP-3859335-B1 | MEMBRANE CARRIER FOR TEST KIT AND TEST KIT | DENKA COMPANY LTD (JP) | 2024-10-02 | — | — | EP | disclosed |
| EP-1072688-A1 | METHOD FOR IN VIVO DETECTING TARGET PROTEIN GENE BY DRUG | Hidaka, Hiroyoshi (JP) | 2001-01-31 | — | — | EP | disclosed |
| US-5916585-A | POLYMERIC SURFACTANTS ATTACHED ONTO THE SURFACES OF A SUPPORT MEMBER AND COVALENTLY CROSS-LINKED THEREON TO FORM A FIRST LAYER. HYDROPHILIC POLYMERS ARE THEN ATTACHED TO THE FIRST LAYER ON THE SUPPORT MEMBER TO FORM A SECOND LAYER THEREON. | GORE ENTERPRISE HOLDINGS, INC. (US) | 1999-06-29 | — | — | US | disclosed |
| EP-0870826-A1 | NOVEL PROTEIN AND MONOCLONAL ANTIBODY SPECIFIC THERETO | FUJI YAKUHIN KOGYO KABUSHIKI KAISHA (JP) | 1998-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11357865-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | NCL, NSUN3, POLN | PSMB8 1954/4885PSMB5 1237/4885MGLL 4186/4885 |
| US-20220370635-A1 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY | NCL, NSUN3, POLN | PSMB8 1954/4885PSMB5 1237/4885MGLL 4186/4885 |
| US-20210330810-A1 | COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY | NCL, NSUN3, POLN | PSMB8 1954/4885PSMB5 1237/4885MGLL 4186/4885 |
| US-20030170692-A1 | Organic conductor | DNMT1, DNMT3A, POLN | PSMB8 4855/4885PSMB5 4884/4885MGLL 4740/4885 |
| US-12472267-B2 | Compositions containing nucleic acid nanoparticles with modular functionality | NCL, NSUN3, POLN | PSMB8 1954/4885PSMB5 1237/4885MGLL 4186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.